RS59967B1 - Semisolid self-microemulsifying drug delivery systems with acyclovir filled in hard capsules, their preparation and application - Google Patents

Semisolid self-microemulsifying drug delivery systems with acyclovir filled in hard capsules, their preparation and application

Info

Publication number
RS59967B1
RS59967B1 RS20170527A RSP20170527A RS59967B1 RS 59967 B1 RS59967 B1 RS 59967B1 RS 20170527 A RS20170527 A RS 20170527A RS P20170527 A RSP20170527 A RS P20170527A RS 59967 B1 RS59967 B1 RS 59967B1
Authority
RS
Serbia
Prior art keywords
acyclovir
filled
self
semisolid
preparation
Prior art date
Application number
RS20170527A
Other languages
Serbian (sr)
Inventor
Ljiljana Đekić
Jovana Janković
Original Assignee
Dekic Ljiljana
Jankovic Jovana
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dekic Ljiljana, Jankovic Jovana filed Critical Dekic Ljiljana
Priority to RS20170527A priority Critical patent/RS59967B1/en
Publication of RS20170527A1 publication Critical patent/RS20170527A1/en
Publication of RS59967B1 publication Critical patent/RS59967B1/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

<p>The invention relates to the production of semi-solid self-microemulsifying systems with an acyclovir filled in hard (two-part) capsules of size 0, which have physico-chemical and biopharmaceutical characteristics of pharmaceutical preparations for oral administration with modified release acyclovir, which is preferably a precondition for improving the absorption of the active substance. The semi-solid self-microemulsifying systems of the invention in addition to acyclovir (2% -33.33%) contain: oil (medium long chain triglycerides) (5% -10%), surfactant (surfactant type macrogolglycerol hydroxystearate) (5% -40%), a cosurfactant (an active ingredient of polyglycerol esters) (2% -20%) and a hydrophilic coating agent (polyol) (10% to 30%). The invention also provides the procedures for obtaining them.</p>
RS20170527A 2017-05-25 2017-05-25 Semisolid self-microemulsifying drug delivery systems with acyclovir filled in hard capsules, their preparation and application RS59967B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
RS20170527A RS59967B1 (en) 2017-05-25 2017-05-25 Semisolid self-microemulsifying drug delivery systems with acyclovir filled in hard capsules, their preparation and application

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RS20170527A RS59967B1 (en) 2017-05-25 2017-05-25 Semisolid self-microemulsifying drug delivery systems with acyclovir filled in hard capsules, their preparation and application

Publications (2)

Publication Number Publication Date
RS20170527A1 RS20170527A1 (en) 2018-11-30
RS59967B1 true RS59967B1 (en) 2020-03-31

Family

ID=64558271

Family Applications (1)

Application Number Title Priority Date Filing Date
RS20170527A RS59967B1 (en) 2017-05-25 2017-05-25 Semisolid self-microemulsifying drug delivery systems with acyclovir filled in hard capsules, their preparation and application

Country Status (1)

Country Link
RS (1) RS59967B1 (en)

Also Published As

Publication number Publication date
RS20170527A1 (en) 2018-11-30

Similar Documents

Publication Publication Date Title
US10617733B2 (en) Orally consumable cannabinoid composition including lecithin
KR20210055042A (en) “Solid self-emulsifying pharmaceutical composition”
CN104427976B (en) Hydrophobic depot formulations of active ingredient and preparation method thereof
WO2010117873A3 (en) Progesterone solutions for increased bioavailability
GB0814302D0 (en) Compounds and methods
CN105142631A (en) Cancer drug and uses
US11160759B1 (en) Capsule with internal diaphragm for improved bioavailability
WO2007027941A3 (en) Compositions and methods for preparation of poorly water soluble drugs with increased stability
WO2008120711A1 (en) Tamibarotene capsule preparation
WO2010032140A3 (en) Pharmaceutical compositions and related methods of delivery
CA3011103A1 (en) Compositions and methods for intravenous administration of 2-bromo-1-(3,3-dinitroazetidin-1-yl)ethanone
NZ581589A (en) Solubilized sterile injectable formulation of docetaxel without Tween 80
EP2377517A4 (en) Pharmaceutical composition containing an anionic drug, and a production method therefor
BRPI0710611A2 (en) pharmaceutical compositions and their uses
JP6094388B2 (en) Injectable composition comprising pemetrexed
JP6796638B2 (en) Topical formulations and their use for the delivery of hedgehog inhibitory compounds
CO6210803A2 (en) FORMULATIONS LIQUID FORMERS OF DERMIC FILM FOR THE RELEASE OF PHARMACO TO THE SKIN
WO2011118976A3 (en) Pharmaceutical composition for the prevention or the treatment of non-alcoholic fatty liver disease and the method for prevention or treatment of non-alcoholic fatty liver disease using the same
NZ631833A (en) Emulsion formulations
TW201350107A (en) Topical pharmaceutical compositions
US20140371242A1 (en) Azathioprine Oral Suspensions and Methods of Use
TW202005652A (en) Pharmaceutical formulation
MX2010004556A (en) Pharmaceutical formulation of clavulanic acid.
US9504751B2 (en) Stable pharmaceutical composition
WO2005115346A3 (en) Pharmaceutical composition containing risperidone